期刊文献+

基因芯片分析前列腺癌细胞系中转移相关基因

Microarray in screening of prostate cancer metastasis associated genes
下载PDF
导出
摘要 目的:通过基因芯片技术检测具有不同转移潜能的前列腺癌细胞系LNCaP和C4-2中表达差异的基因,寻找前列腺癌转移相关基因。方法:采用TRIzol一步法提取LNCaP和C4-2细胞的总RNA,并纯化mRNA,反转录合成荧光分子标记的c DNA探针,与基因芯片杂交。采用Genepix Pro 6.0图像分析软件进行芯片图像分析,把图像信号转化为数字信号,然后以差异大于等于2倍的标准来确定差异表达基因。结果:在LNCaP与C4-2细胞中,表达差异的基因共有417个,上调基因301个,下调基因116个。分析显示差异表达基因分别与细胞增殖、代谢、细胞因子、细胞转移等相关,其中发现7个基因与肿瘤细胞的转移相关,分别为EGFR、EGF、PIK3R1、Cyclin E、HYAL1、GNAI1、AZGP1。结论:筛选出LNCaP与C4-2细胞系中7个转移相关基因,为进一步研究前列腺癌转移机制奠定了基础。 Objective: The gene expression profiles of two cell lines( LNCaP and C4-2) with different metastatic potentials were examined using DNA microarray technology to identify the molecular causes of prostate cancer metastasis. Methods: Total RNA was extracted and purified,and then reverse transcript to c DNA,hybridized according to the agilent chip instructions. The fluorescent signals were analyzed and displayed by using Genepix Pro 6. 0 to find differential expressed genes between LNCaP and C4-2 cells with the standard of 2-fold deferential expression. Results:The microarray results revealed that 301 genes were up-regulated and 116 genes were down-regulated among screened 417 genes which were associated with proliferation,cell metabolism,growth factors,metastatic potential. EGFR,EGF,PIK3R1,Cyclin E,HYAL1,GNAI1,AZGP1 were related to prostate cancer metastasis. Conclusion: Seven differential expressed genes in LNCaP and C4-2 cell lines are related to prostate cancer metastasis and this study provides the theory basis to explore the molecular mechanism of prostate cancer metastasis.
出处 《现代肿瘤医学》 CAS 2016年第8期1181-1183,共3页 Journal of Modern Oncology
关键词 基因芯片 LNCAP细胞 C4-2细胞 转移 前列腺癌 microarray technology LNCaP cell C4-2 cell metastasis prostate cancer
  • 相关文献

参考文献5

二级参考文献55

  • 1邓晶,何江娟,钟林,徐农.恶性肿瘤患者化疗期间生活质量研究[J].实用肿瘤杂志,2007,22(1):48-50. 被引量:48
  • 2Bang Y.I, Van Cutsem E, Feyereislova A, et al. Trastuzumab in com- bination with chemotherapy versus chemotherapy alone for treat- ment of HER2 - positive advanced gastric or gastro - oesophageal junction cancer (TOGA) : a phase 3, open - label, randomised con- trolled trial [ J ]. Lancet,2010,376 (9742) :687 - 697.
  • 3Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers[ J]. Int J Cancer, 2006,118(2) :257 -262.
  • 4Tamas P, Solti Z, Bauer P, et al. Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac [ J ]. J Biol Chem, 2003,278 ( 7 ) : 5163 - 5171.
  • 5Lordick F, Luber B, Lorenzen S, et al. Cetuximab plus oxaliplatin / leucovorin/5 - fluorouracil in first - line metastatic gastric cancer: a phase Ⅱ study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) [J]. Br J Cancer,2010,102 (3) :500 -505.
  • 6Okamoto I. Epidermal growth factor receptor in relation to tumor de- velopment EGFR - targeted anticancer therapy[ J]. FEBS J,2010, 277(2) :309 -315.
  • 7Goueli BS, Janknecht R. Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2 / Neu, Ras, or Raf[ J ]. Mol Cell Biol,2004,24 ( 1 ) :25 - 35.
  • 8Finkenzeller G, Weindel K, Zimmermann W, et al. Activated Neu / ErbB -2 induces expression of the vascular endothelial growth fac- tor gene by functional activation of the transcription factor Spl [ J]. Angiogenesis ,2004,7 ( 1 ) :59 -68.
  • 9Hsu Jr, Chen TC, Tseng JH, et al. Impact of HER2 overexpression/ amplification on the prognosis of gastric Cancer patients undergoing resection : a single - center study of '1036 patients [ J ]. Oncologist, 2011,16(12) :1706 - 17~3.
  • 10Hohler T, Rtlschoff J, Ridwelski K, et al. HER2 testing and targeted therapy in advanced gastric cancer[ J]. Onkologie,2010,33 ( Suppl 4) :26 -30.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部